Dr. Reddy’s announces the Launch of Paricalcitol Capsules

Dr. Reddy’s announces the Launch of Paricalcitol Capsules

India, Jun 25, 2014 (BUSINESS WIRE) -- Dr. Reddy’s Laboratories announced today that it has launched Paricalcitol Capsules, 1 mcg, 2 mcg and 4 mcg, a therapeutic equivalent generic version of ZEMPLAR (Paricalcitol) Capsules in the US market on June 24, 2014, following the approval by the United States Food & Drug Administration (USFDA).

The ZEMPLAR® brand and generic had U.S. sales of approximately $109.6 Million MAT for the most recent twelve months ending in March 2014 according to IMS Health*.

Dr. Reddy’s Paricalcitol Capsules 1 mcg, 2 mcg and 4 mcg are available in bottle counts of 30.

Disclaimer

This press release includes forward-looking statements, as defined in the U.S. Private Securities Litigation Reform Act of 1995. We have based these forward-looking statements on our current expectations and projections about future events. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. Such factors include, but are not limited to, changes in local and global economic conditions, our ability to successfully implement our strategy, the market acceptance of and demand for our products, our growth and expansion, technological change and our exposure to market risks. By their nature, these expectations and projections are only estimates and could be materially different from actual results in the future.